A new Haleon report claims pain shoots up over decade
Consumer health company Haleon suggests that the emotional and life impact of pain has gone up by 25 per cent in the past decade.
The...
Haleon not surprised by Pfizer stake sale plans, says CFO
Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday (3 May).
London-listed...
Sensodyne revitalises formula and packaging for sensitivity and gum range
Sensodyne, the No.1 dentist recommended toothpaste brand for sensitive teeth is relaunching its Sensitivity & Gum range with an improved formula and revitalized packaging....
Haleon’s Proton Pump Inhibitors (PPIs) witnessed 13% growth in pharmacy recommendations
Despite a 13 per cent increase from last year, less than a quarter (21%) of pharmacy teams recommend Proton Pump Inhibitors (PPIs) as a...
New GSK raises 2022 forecast for second time in four months
New GSK raised its 2022 forecast for the second time this year, after third-quarter earnings and sales topped estimates, continuing its strong start as...
EXCLUSIVE: Raising the bar for patient care
Global consumer healthcare company Haleon has launched a new center of excellence for a global leader in consumer health which will bring together world...